14-day Premium Trial Subscription Sign Up For FreeGet Free

BiondVax Pharmaceuticals Ltd. Stock Forecast NASDAQ:BVXV

$1.83 (-1.28%)

Volume: 97k

Closed: Nov 29, 2021

Hollow Logo Score: -2.924

BiondVax Pharmaceuticals Ltd. Stock Forecast

$1.83 (-1.28%)

Volume: 97k

Closed: Nov 29, 2021

Score Hollow Logo -2.924
Which way will BVXV go? Request
Key Stats
Beta 1.4
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The BiondVax Pharmaceuticals Ltd. stock currently holds an RSI14 at 21 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

BiondVax Pharmaceuticals Ltd. stock price down 1.28% on Monday
(Updated on Nov 29, 2021)

Sell candidate since 2021-11-16 Loss -15.45%

The BiondVax Pharmaceuticals Ltd. stock price fell by -1.28% on the last day (Monday, 29th Nov 2021) from $1.85 to $1.83. During the day the stock fluctuated 7.42% from a day low at $1.72 to a day high of $1.85. The price has fallen in 7 of the last 10 days and is down by -16.61% for this period. Volume has increased on the last day by 35 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 97 thousand shares were bought and sold for approximately $176.42 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.75 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -15.34% during the next 3 months and, with a 90% probability hold a price between $1.48 and $1.93 at the end of this 3-month period.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, November 23, 2021, and so far it has risen 3.18%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BiondVax Pharmaceuticals Ltd. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.91 and $2.16. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). BiondVax Pharmaceuticals Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss

BiondVax Pharmaceuticals Ltd. finds support from accumulated volume at $1.77 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 7.42%. For the last week, the stock has had a daily average volatility of 10.24%.

BiondVax Pharmaceuticals Ltd. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is BiondVax Pharmaceuticals Ltd. stock A Buy?

BiondVax Pharmaceuticals Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.924

Predicted Opening Price for BiondVax Pharmaceuticals Ltd. of Tuesday, November 30, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 30, 2021 Current price
$1.80 $1.83 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 10.24 %
Overall Risk: Very High High Medium Low Very Low
10.24 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $2.11
Price: $1.83
Support: $1.77

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.93 5.53 %
1.88 2.86 %
1.85 1.21 %
Current price: 1.83
Support 1.75 -4.14 %
1.72 -5.79 %
1.67 -8.47 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 2.25 23.20 %
2.18 19.37 %
2.11 15.53 %
Current price 1.83
Support 1.77 -3.08%
0 .
0 .

Click to get the best stock tips daily for free!

About BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd Biondvax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. The company offers M-001, a synthetic peptide-based protein, which is in Phase 2 clinical development stage targeting seasonal and pandemic strains of the influenza virus. Biondvax Pharmaceuticals Ltd. was founded in 2003 and is based in Ness Ziona, Israel.... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE